0001156175-17-000027.txt : 20171006
0001156175-17-000027.hdr.sgml : 20171006
20171006161447
ACCESSION NUMBER: 0001156175-17-000027
CONFORMED SUBMISSION TYPE: SC 13G
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20171006
DATE AS OF CHANGE: 20171006
GROUP MEMBERS: BROOKSIDE CAPITAL INVESTORS II, L.P.
GROUP MEMBERS: BROOKSIDE CAPITAL TRADING FUND, L.P.
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Immune Design Corp.
CENTRAL INDEX KEY: 0001437786
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262007174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-88256
FILM NUMBER: 171127367
BUSINESS ADDRESS:
STREET 1: 1616 EASTLAKE AVE. E
STREET 2: SUITE 310
CITY: SEATTLE
STATE: WA
ZIP: 98102
BUSINESS PHONE: (206) 682-0645
MAIL ADDRESS:
STREET 1: 1616 EASTLAKE AVE. E
STREET 2: SUITE 310
CITY: SEATTLE
STATE: WA
ZIP: 98102
FORMER COMPANY:
FORMER CONFORMED NAME: VACCSYS INC
DATE OF NAME CHANGE: 20080617
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: Bain Capital Public Equity Management, LLC
CENTRAL INDEX KEY: 0001156175
IRS NUMBER: 043517087
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: SC 13G
BUSINESS ADDRESS:
STREET 1: 200 CLARENDON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-516-2000
MAIL ADDRESS:
STREET 1: 200 CLARENDON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: BROOKSIDE CAPITAL MANAGEMENT LLC
DATE OF NAME CHANGE: 20010801
SC 13G
1
ImmuneInitial13G.txt
IMMUNE DESIGN SCHEDULE 13G
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. ________)*
Immune Design Corp. (Name of Issuer)
Common Stock
(Title of Class of Securities)
45252L103 (CUSIP Number)
September 29, 2017
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant
to which this Schedule is filed:
? Rule 13d-1(b)
? Rule 13d-1(c)
? Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect
to the subject class of securities, and for any subsequent
amendment containing information which would alter disclosures
provided in a prior cover page.
The information required on the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section
18 of the Securities Exchange Act of 1934 ("Act") or otherwise
subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the Notes).
CUSIP No. 45252L103
13G
Page 2 of 8
1.
NAMES OF REPORTING PERSONS
Bain Capital Public Equity Management, LLC
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a) ?
(b) ?
3.
SEC USE ONLY
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
5.
SOLE VOTING POWER
1,299,013
6.
SHARED VOTING POWER
0
7.
SOLE DISPOSITIVE POWER
1,299,013
8.
SHARED DISPOSITIVE POWER
0
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,299,013
10.
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see instructions) ?
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.07%
12.
TYPE OF REPORTING PERSON (see instructions)
PN
CUSIP No. 45252L103
13G
Page 3 of 8
1.
NAMES OF REPORTING PERSONS
Brookside Capital Investors II, L.P.
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a) ?
(b) ?
3.
SEC USE ONLY
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
5.
SOLE VOTING POWER
1,299,013
6.
SHARED VOTING POWER
0
7.
SOLE DISPOSITIVE POWER
1,299,013
8.
SHARED DISPOSITIVE POWER
0
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,299,013
10.
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see instructions) ?
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.07%
12.
TYPE OF REPORTING PERSON (see instructions)
PN
CUSIP No. 45252L103
13G
Page 4 of 8 Pages
1.
NAMES OF REPORTING PERSONS
Brookside Capital Trading Fund, L.P.
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a) ?
(b) ?
3.
SEC USE ONLY
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
5.
SOLE VOTING POWER
1,299,013
6.
SHARED VOTING POWER
0
7.
SOLE DISPOSITIVE POWER
1,299,013
8.
SHARED DISPOSITIVE POWER
0
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,299,013
10.
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see instructions) ?
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.07%
12.
TYPE OF REPORTING PERSON (see instructions)
PN
CUSIP No. 45252L103
13G
Page 5 of 8
Item 1.
(a)
Name of Issuer
The name of the issuer to which this filing on Schedule 13G
relates is Immune Design Corp. (the "Company")
(b)
Address of Issuer's Principal Executive Offices
The principal executive offices of the Company are located at
1616 Eastlake Ave. E, Suite 310, Seattle WA 98102
Item 2.
(a)
Name of Person Filing
This Statement is being filed on behalf the following (collectively,
the "Reporting Persons"): Brookside Capital Trading Fund, L.P., a
Delaware limited partnership ("Trading Fund"), whose sole general
partner is Brookside Capital Investors II, L.P., a Delaware limited
partnership ("Brookside Investors II"), whose sole general partner
is Bain Capital Public Equity Management, LLC, a Delaware limited
liability company ("BCPE Management").
The Reporting Persons have entered into a Joint Filing Agreement,
dated October 6, 2017, a copy of which is filed with this Schedule
13G as Exhibit A, pursuant to which the Reporting Persons have agreed
to file this statement jointly in accordance with the provisions of
Rule 13d-1(k)(1) under the Securities Exchange Act of 1934.
(b)
Address of the Principal Office or, if none, residence
The principal business address of each of the Trading Fund, Brookside
Investors II and BCPE Management is c/o Bain Capital Public Equity, LP,
200 Clarendon Street, Boston, MA 02116.
(c)
Citizenship
Each of the Trading Fund, Brookside Investors II and BCPE Management
is organized under the laws of the State of
Delaware.
(d)
Title of Class of Securities
The class of equity securities of the Company to which this filing on
Schedule 13G relates is Common Stock
("Common Stock").
(e)
CUSIP Number
The CUSIP number of the Company's Common Stock is 45252L103.
Item 3. If this statement is filed pursuant to 240.13d-1(b) or
240.13d-2(b) or (c), check whether the person filing is a:
(a)
?
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
(b)
?
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
(c)
?
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
(d)
?
Investment company registered under section 8 of the Investment Company
Act of 1940 (15 U.S.C. 80a-8).
(e)
?
An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E);
(f)
?
An employee benefit plan or endowment fund in accordance with
240.13d-1(b)(1)(ii)(F);
(g)
?
A parent holding company or control person in accordance with
240.13d-1(b)(1)(ii)(G);
(h)
?
A savings associations as defined in Section 3(b) of the Federal Deposit
Insurance Act (12 U.S.C. 1813);
(i)
?
A church plan that is excluded from the definition of an investment
company under section 3(c)(14) of the Investment Company Act
of 1940 (15 U.S.C. 80a-3);
(j)
?
Group, in accordance with 240.13d-1(b)(1)(ii)(J).
[x] If this statement is filed pursuant to 240.13d-1(c), check this box.
Item 4. Ownership.
Provide the following information regarding the aggregate number and
percentage of the class of securities of the issuer
identified in Item 1.
(a)
Amount beneficially owned: 1,299,013.
(b)
Percent of class: 5.07% based upon 25,619,732 shares
of Common Stock outstanding.
(c)
Number of shares as to which the person has: 1,299,013.
(i)
Sole power to vote or to direct the vote: 1,299,013.
(ii)
Shared power to vote or to direct the vote: 0.
(iii)
Sole power to dispose or to direct the disposition of: 1,299,013.
(iv)
Shared power to dispose or to direct the disposition of: 0.
Item 5. Ownership of Five Percent or Less of a Class.
Not applicable.
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Not applicable.
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent
Holding Company.
Not applicable.
Item 8. Identification and Classification of Members of the Group.
Not applicable.
Item 9. Notice of Dissolution of Group.
Not applicable.
Item 10. Certification.
By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were not acquired and are not held for
the purpose of or with the effect of changing or influencing the control
of the issuer of the securities and were not acquired and are not held
in connection with or as a participant in any transaction having that
purpose or effect.
CUSIP No. 45252L103
13G
Page 7 of 8
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement
is true, complete and correct.
Dated: October 6, 2017
BAIN CAPITAL PUBLIC EQUITY MANAGEMENT, LLC
By:
Name: Joshua Ross
Title: Managing Director
BROOKSIDE CAPITAL INVESTORS II, L.P.
By: Bain Capital Public Equity Management, LLC,
its general partner
By:
Name: Joshua Ross
Title: Managing Director
BROOKSIDE CAPITAL TRADING FUND, L.P.
By: Brookside Capital Investors II, L.P.,
its general partner
By: Bain Capital Public Equity Management, LLC,
its general partner
By:
Name: Joshua Ross
Title: Managing Director
Exhibit A
AGREEMENT REGARDING THE JOINT FILING OF
SCHEDULE 13G
The undersigned hereby agree as follows:
(i) The Statement on Schedule 13G, and any amendments thereto,
to which this Agreement is annexed as Exhibit A is and will be
filed on behalf of each of them in accordance with the provisions
of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934,
as amended; and
(ii) Each of them is responsible for the timely filing of such
Schedule 13G and any amendments thereto, and for the completeness
and accuracy of the information concerning such person contained
therein; but none of them is responsible for the completeness
or accuracy of the information concerning the other persons
making the filing, unless such person knows or has reason to
believe that such information is inaccurate.
Dated: October 6, 2017
BAIN CAPITAL PUBLIC EQUITY MANAGEMENT, LLC
By:
Name: Joshua Ross
Title: Managing Director
BROOKSIDE CAPITAL INVESTORS II, L.P.
By: Bain Capital Public Equity Management, LLC,
its general partner
By:
Name: Joshua Ross
Title: Managing Director
BROOKSIDE CAPITAL TRADING FUND, L.P.
By: Brookside Capital Investors II, L.P.,
its general partner
By: Bain Capital Public Equity Management, LLC,
its general partner
By:
Name: Joshua Ross
Title: Managing Director
The percentage of Common Stock reported owned by the Reporting Persons
is based upon 25,619,732 shares of Common Stock outstanding as reported
in the Issuer's Quarterly Report on Form 10-Q dated June 30, 2017.
The percentage of Common Stock reported owned by the Reporting Persons
is based upon 25,619,732 shares of Common Stock outstanding as reported
in the Issuer's Quarterly Report on Form 10-Q dated June 30, 2017. The
percentage of Common Stock reported owned by the Reporting Persons is
based upon 25,619,732 shares of Common Stock outstanding as reported
in the Issuer's Quarterly Report on Form 10-Q dated June 30, 2017.
48220740_1
48220740_1
48220740_1
48220740_1